author-photo

Jennifer S Ko

Cleveland Clinic Lerner Research Institute

6

Papers

19

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

A phase II trial of nivolumab in combination with talazoparib in unresectable or metastatic melanoma patients with mutations in BRCA or BRCAness.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Myeloid derived suppressor cells (MDSC) and inflammatory biomarkers in metastatic urothelial carcinoma (mUC).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Serial measurements of myeloid derived suppressor cells (MDSC) in metastatic urothelial carcinoma (mUC) patients (pts) treated with immune checkpoint inhibitors (CI).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
BOLERO-1: A randomized, phase III, double-blind, placebo-controlled multicenter trial of everolimus in combination with trastuzumab and paclitaxel as first-line therapy in women with HER2-positive (HER2+), locally advanced or metastatic breast cancer (BC).

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (15)